- Catalyst
... • Ladd’s procedure on initial hospitalization was associated with a 2.2x increase in odds of major morbidity or mortality (p=0.007) • Suggest that in an asymptomatic patient with HS, even with IRA seen on upper GI, cautious observation is safest. ...
... • Ladd’s procedure on initial hospitalization was associated with a 2.2x increase in odds of major morbidity or mortality (p=0.007) • Suggest that in an asymptomatic patient with HS, even with IRA seen on upper GI, cautious observation is safest. ...
Reflections on ethical issues in palliative care for patients with heart
... benefit or are detrimental to the patient’s wellbeing and quality of life.9 If a new treatment is considered by the physician to be futile or of little benefit, the physician is not compelled to start it, although careful discussion and explanation with the patient and family is needed. Cardiopulmon ...
... benefit or are detrimental to the patient’s wellbeing and quality of life.9 If a new treatment is considered by the physician to be futile or of little benefit, the physician is not compelled to start it, although careful discussion and explanation with the patient and family is needed. Cardiopulmon ...
Heart - ShevClasses
... order to allow gravity to help in the flow of blood to the heart and brain. 5. Cardiac arrest: This is a term which simply means that the heart stops. ...
... order to allow gravity to help in the flow of blood to the heart and brain. 5. Cardiac arrest: This is a term which simply means that the heart stops. ...
Evia HF (-T): the world`s first magnetic resonance approved pace
... patients suffering from mild-to-severe chronic congestive heart failure according to current guidelines and to reduce related symptoms through resynchronization of both ventricles. The technical innovations implemented in the device are esentially the same that make the entire Evia PM family (which ...
... patients suffering from mild-to-severe chronic congestive heart failure according to current guidelines and to reduce related symptoms through resynchronization of both ventricles. The technical innovations implemented in the device are esentially the same that make the entire Evia PM family (which ...
Secundum Atrial Septal Defect (ASD)
... contractions (PVCs) and fixed splitting of his second heart sound (S2) on physical exam underwent a transthoracic echocardiogram (TTE) to assess for underlying structural heart disease. His TTE was notable for mild right atrial (RA) enlargement, moderate right ventricular (RV) dilatation, and the pr ...
... contractions (PVCs) and fixed splitting of his second heart sound (S2) on physical exam underwent a transthoracic echocardiogram (TTE) to assess for underlying structural heart disease. His TTE was notable for mild right atrial (RA) enlargement, moderate right ventricular (RV) dilatation, and the pr ...
Prognostic Value of Extravascular Lung Water Assessed With
... Echocardiographic data on the filling pressure (e/e0 ratio) were not available in the present study population. However, in a previous study from our group, Agricola et al.23 described a linear correlation between the ULC number and the e/e0 , both in resting conditions (r 5 0.70) and during exercis ...
... Echocardiographic data on the filling pressure (e/e0 ratio) were not available in the present study population. However, in a previous study from our group, Agricola et al.23 described a linear correlation between the ULC number and the e/e0 , both in resting conditions (r 5 0.70) and during exercis ...
this PDF file - Pakistan Heart Journal
... The low cardiac output syndrome (or low output syndrome) is a serious clinical situation of inadequate tissue perfusion due to myocardial dysfunction that often occurs at termination of cardiopulmonary bypass (CPB) or shortly thereafter. It is usually transient and reversible, but persistent LCOS is ...
... The low cardiac output syndrome (or low output syndrome) is a serious clinical situation of inadequate tissue perfusion due to myocardial dysfunction that often occurs at termination of cardiopulmonary bypass (CPB) or shortly thereafter. It is usually transient and reversible, but persistent LCOS is ...
Guidelines For Management of Acute Coronary
... patients with a serum creatinine of <2 mg/dL, or 1 mcg/kg/min in patients with a serum creatinine > 2.0 but < 4.0 mg/dL will be administered for 18 hours. For patients transferred from cath lab to the inpatient unit on abciximab (Reopro), it will be continued at a dose of 0.125 mcg/kg/min (maximum ...
... patients with a serum creatinine of <2 mg/dL, or 1 mcg/kg/min in patients with a serum creatinine > 2.0 but < 4.0 mg/dL will be administered for 18 hours. For patients transferred from cath lab to the inpatient unit on abciximab (Reopro), it will be continued at a dose of 0.125 mcg/kg/min (maximum ...
Electrical properties - Akademik Ciamik 2010
... • Depolarization phase followed by rapid, partial early depolarization and then the plateau phase and ended by final repolarization phase • Depolarization is due to the opening of voltage-gated Na+ channels and reaches approximately (+)20 mV • During depolarization voltage-gated K+ channels are clos ...
... • Depolarization phase followed by rapid, partial early depolarization and then the plateau phase and ended by final repolarization phase • Depolarization is due to the opening of voltage-gated Na+ channels and reaches approximately (+)20 mV • During depolarization voltage-gated K+ channels are clos ...
After atrial excitation, impulse travels through the AV node
... After atrial excitation, impulse travels through the AV node & specialised conduction system to excite the ventricle. Simultaneously atria are contracting, and by the time ventricular activation is complete, atr ...
... After atrial excitation, impulse travels through the AV node & specialised conduction system to excite the ventricle. Simultaneously atria are contracting, and by the time ventricular activation is complete, atr ...
Heart Defect Closure Without Surgery
... will be required for closure of ASD or PFO. This is done by passing a probe down your throat. Suitability is assessed by looking at the size and the position of the defect, as well as if there are any other associated congenital abnormalities in your heart. Once the defect is found suitable for clos ...
... will be required for closure of ASD or PFO. This is done by passing a probe down your throat. Suitability is assessed by looking at the size and the position of the defect, as well as if there are any other associated congenital abnormalities in your heart. Once the defect is found suitable for clos ...
ISHEMIC CONDITIONING - EVIDENCE REVIEW DR SANMATH
... Combined RIC and PostC significantly increases myocardial salvage when compared with conventional PCI whereas PostC alone failed to demonstrate a cardioprotective effect in STEMI patients undergoing primary PCI. Should be further investigated in future well-designed clinical trials powered for the ...
... Combined RIC and PostC significantly increases myocardial salvage when compared with conventional PCI whereas PostC alone failed to demonstrate a cardioprotective effect in STEMI patients undergoing primary PCI. Should be further investigated in future well-designed clinical trials powered for the ...
Patient Guide to Understanding Atrial Fibrillation
... There are a number of treatment options for AF, and there is no single way to treat AF that is right for everybody. Every patient is unique, as there are many causes of AF. You should discuss your treatment options with your doctor; however, there are a few standard approaches of which you should be ...
... There are a number of treatment options for AF, and there is no single way to treat AF that is right for everybody. Every patient is unique, as there are many causes of AF. You should discuss your treatment options with your doctor; however, there are a few standard approaches of which you should be ...
Ventricular Tachycardia and Premature Ventricular Contractions
... – Adenosine (6-24mg), verapamil (diltiazem), BB ...
... – Adenosine (6-24mg), verapamil (diltiazem), BB ...
Locum Consultant Cardiologist with an interest in Cardiac
... The Golden Jubilee Research Institute facilitates and supports high quality research, which conforms to the quality standards required by guidance (the Research Governance Framework for Health and Community Care SGHD 2006) and legislation (the EU Clinical Trials Directive). It hosts projects sponsor ...
... The Golden Jubilee Research Institute facilitates and supports high quality research, which conforms to the quality standards required by guidance (the Research Governance Framework for Health and Community Care SGHD 2006) and legislation (the EU Clinical Trials Directive). It hosts projects sponsor ...
Stroke Event in Complete Heart Block and Sinus Node Dysfunction
... heartbeat, a bradycardia of 32 - 40 beat per minute. Sinus node dysfunction is referred to as sick sinus syndrome when it is accompanied by symptoms such as dizziness or syncope. Complete heart block is complete failure of conduction between the atria and ventricles. In adults, the most common cause ...
... heartbeat, a bradycardia of 32 - 40 beat per minute. Sinus node dysfunction is referred to as sick sinus syndrome when it is accompanied by symptoms such as dizziness or syncope. Complete heart block is complete failure of conduction between the atria and ventricles. In adults, the most common cause ...
Coronary artery bypass graft (CABG) surgery
... proximal graft anastomosis. The ascending aorta was very calcific, cheesy and abnormally thinwalled and atherosclerotic. Four patients (about 2.5%) were reexplored for bleeding which was better than most world series of about 10%.1 Except for chest infections there were no other significant major cl ...
... proximal graft anastomosis. The ascending aorta was very calcific, cheesy and abnormally thinwalled and atherosclerotic. Four patients (about 2.5%) were reexplored for bleeding which was better than most world series of about 10%.1 Except for chest infections there were no other significant major cl ...
Adult Congenital Heart Disease - STA HealthCare Communications
... fixed splitting of the second heart sound. A systolic ejection murmur at the upper sternal border is heard in most patients due to increased flow across the RV outflow tract. In very rare cases, patients might develop severe (and often irreversible) pulmonary hypertension and may have cyanosis and c ...
... fixed splitting of the second heart sound. A systolic ejection murmur at the upper sternal border is heard in most patients due to increased flow across the RV outflow tract. In very rare cases, patients might develop severe (and often irreversible) pulmonary hypertension and may have cyanosis and c ...
Electrophysiologic backround for ECG evaluation
... 7) Each abnormality should be taken into accont ...
... 7) Each abnormality should be taken into accont ...
Thirty-Five Years of Mechanical Circulatory Support at the Texas
... at THI in November 2003 in an 18-year-old man who had dilated cardiomyopathy. The patient was successfully rehabilitated and was discharged in April 2004 after the FDA granted permission for study patients to be discharged home to await transplant. The HeartMate II has been implanted in 8 patients a ...
... at THI in November 2003 in an 18-year-old man who had dilated cardiomyopathy. The patient was successfully rehabilitated and was discharged in April 2004 after the FDA granted permission for study patients to be discharged home to await transplant. The HeartMate II has been implanted in 8 patients a ...
Congestive Heart Failure
... An ACR Committee on Appropriateness Criteria and its expert panels have developed criteria for determining appropriate imaging examinations for diagnosis and treatment of specified medical condition(s). These criteria are intended to guide radiologists, radiation oncologists, and referring physician ...
... An ACR Committee on Appropriateness Criteria and its expert panels have developed criteria for determining appropriate imaging examinations for diagnosis and treatment of specified medical condition(s). These criteria are intended to guide radiologists, radiation oncologists, and referring physician ...
Frequently Asked Questions
... patients that would benefit from them. Assuming MADIT II and SCD-HeFT are positive, we anticipate that MTWA will play a critical roll in risk stratifying those patients that would most likely benefit from ICD therapy. 8. What are the mechanisms of Microvolt T-Wave Alternans? ...
... patients that would benefit from them. Assuming MADIT II and SCD-HeFT are positive, we anticipate that MTWA will play a critical roll in risk stratifying those patients that would most likely benefit from ICD therapy. 8. What are the mechanisms of Microvolt T-Wave Alternans? ...
... Results: Out of the 50 patients, 33 patients (66%) had abnormal echocardiographic findings. 50% of the patients (25 out of 50 patients.) had diastolic dysfunction while 34% (17 out of 50 patients) had left ventricular hypertrophy. Diastolic dysfunction was highest in patients >60 years of age (90.91 ...
Cardiac contractility modulation
.jpg?width=300)
Cardiac contractility modulation (CCM) is a treatment for patients with moderate to severe left ventricular systolic heart failure (NYHA class II–IV). The short- and long-term use of this therapy enhances both the strength of ventricular contraction and the heart’s pumping capacity. The CCM mechanism is based on stimulation of the cardiac muscle by non-excitatory electrical signals (NES). CCM treatment is delivered by a pacemaker-like device that applies the NES, adjusted to and synchronized with the electrical action in the cardiac cycle.In CCM therapy, electrical stimulation is applied to the cardiac muscle during the absolute refractory period. In this phase of the cardiac cycle, electrical signals cannot trigger new cardiac muscle contractions, hence this type of stimulation is known as a non-excitatory stimulation. However, the electrical CCM signals increase the influx of calcium ions into the cardiac muscle cells (cardiomyocytes). In contrast to other electrical stimulation treatments for heart failure, such as pacemaker therapy or implantable cardioverter defibrillators (ICD), CCM does not affect the cardiac rhythm directly. Rather, the aim is to enhance the heart’s natural contraction (the native cardiac contractility) sustainably over long periods of time. Furthermore, unlike most interventions that increase cardiac contractility, CCM is not associated with an unfavorable increase in oxygen demand by the heart (measured in terms of Myocardial Oxygen Consumption or MVO2). This may be explained by the beneficial effect CCM has in improving cardiac efficiency. A meta-analysis in 2014 and an overview of device-based treatment options in heart failure in 2013 concluded that CCM treatment is safe, that it is generally beneficial to patients and that CCM treatment increases the exercise tolerance (ET) and quality of life (QoL) of patients. Furthermore, preliminary long-term survival data shows that CCM is associated with lower long-term mortality in heart failure patients when compared with expected rates among similar patients not treated with CCM.